Press releases

19.Jul 21

Scandion Oncology announces that its President & CEO has bought 4,500 shares in Scandion Oncology

19.Jul 21

Save the date for the Scandion Oncology Capital Markets Day on September 8, 2021
Scandion Oncology A/S invites investors, analysts, and media to a virtual Cap...

30.Jun 21

Scandion Oncology A/S and Alligator Bioscience AB present promising preclinical data
Copenhagen, Denmark, June 30, 2021 – Scandion Oncology (Nasdaq Stockholm: SCO...

24.Jun 21

Scandion Oncology reports positive interim results from the CORIST Phase II study
Scandion Oncology A/S today reports positive results from the dose-finding pa...

02.Jun 21

Scandion Oncology appoints Johnny Stilou as new CFO
Scandion Oncology A/S today announces that Johnny Stilou has been appointed a...

26.May 21

Scandion Oncology A/S: Minutes of the Annual General Meeting 2021
The Annual General Meeting 2021 of Scandion Oncology A/S (CVR no. 38613391) (...

20.May 21

Q1 2021 Report: Scandion Oncology is evolving

10.May 21

Scandion Oncology A/S: Notice convening the Annual General Meeting 2021
We hereby convene the Annual General Meeting 2021 of Scandion Oncology A/S (t...

29.Apr 21

Annual Report 2020: Scandion Oncology is setting the pace for the future
Scandion Oncology’s Annual Report 2020 has now been published and is availabl...

21.Apr 21

Scandion Oncology engages former ASCO executive as clinical advisor
Scandion Oncology is pleased to announce that we have appointed Dr. Richard L...

Load more (100)